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Abstract
Background: Nigeria has a high tuberculosis incidence, and genotyping studies of Mycobacterium tuberculosis 
Complex (MTC) in the country are necessary in order to improve our understanding of the epidemic.
Methods: Isolates of MTC were isolated from cases of pulmonary tuberculosis in Jos, North Central region of Nigeria 
during 2006-2008. Drug susceptibility test (DST) was performed on 77 of 111 isolates by proportion method on 
Lowenstein Jensen (LJ) slope while genotyping of mycobacterial DNA was performed by spoligotyping. The SpolDB4 
database and the model-based program 'spotclust' were used to assign isolates to families, subfamilies and variants.
Results: A total of 111 pulmonary isolates from consecutive tuberculosis patients in the city of Jos, Plateau State, 
Nigeria were spoligotyped. A total of 84 (76%) of the isolates belonged to the Latin American Mediterranean (LAM) 
family. Of these, 78 isolates were assigned to the LAM10 lineage. Among these, 66 exhibited identical spoligopatterns. 
Drug susceptibility profiles obtained were not consistently associated with any spoligopattern.
Conclusions: The dominance of few M. tuberculosis lineages suggests either a high rate of transmission, frequent 
import of closely related strains, or a highly conserved genotype. It remains to be confirmed whether the 
predominance of identical LAM10 represent an outbreak.
Spoligotyping was useful to gain an overall understanding of the local TB epidemic. This study demonstrated that the 
incidence of TB in Jos, Nigeria may be caused by a few successful M. tuberculosis families, dominated by the LAM10 
family.
Background
Nigeria ranks fifth among the world's high-burden coun-
t r i e s ,  w i t h  a  n u m b e r  o f  t u b e r c u l o s i s  ( T B )  c a s e s  o f
450,000. The TB incidence is at 311/100,000 and the rate
of new sputum smear positive disease is approximately
137/100,000 [1].
Published work on the incidence, drug susceptibility,
and epidemiology of Mycobacterium tuberculosis Com-
plex (MTC) in Jos and in Nigeria are scarce. The results of
the few reported studies did not address epidemiological
concerns [2-5]. Supporting data from additional studies
are therefore needed to better understand the current
epidemic in this area. Nigeria, like most nations of sub
Saharan Africa has been rated endemic for TB due to the
association of Mycobacterium  species with the human
immunodeficiency virus (HIV). It has been reported that
30-45% of HIV positive persons in Nigeria present with
active TB at one point or the other [6].
Points of concern include the proportion of patients
lost to follow-up, diagnostic delay, low case detection rate
and the continuing high prevalence of HIV. The high case
rate in many African countries contributed to a rise of the
global TB incidence of 1% in 2003, despite stable or
declining rates in the rest of the world. The incidence in
Nigeria however, declined by 1.3% between 2005 and
2006 [1]. In order to improve our understanding of the
TB epidemic in this high-incidence country, the current
study included 111 strains of MTC species isolated from
in Jos, Nigeria. For the genetic studies, DNA of all 111
isolates were obtained during three intervals of 2006-
2008. Currently no laboratory in Nigeria offers spoligo-
typing services. Spoligotyping is a PCR-based finger-
printing method that detects the presence or absence of
43 defined spacers situated between short direct repeat
(DR) sequences in the genomes of members of the MTC
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[7]. Important advantages of spoligotyping are that it is
cheap, easy to perform and fast. In addition, it has been
demonstrated that the results are highly reproducible [8].
Unique to spoligotyping results are tools like the SpolDB4
database [9] and the web-based computer algorithm
'Spotclust' [10] that can be used to assign new isolates to
families, subfamilies and variants. The results from local
studies can thus be analyzed and compared to the global
MTC population. This may help to better understand the
world-wide spread of common MTC families and sub-
families. In the current study we describe the diversity of
MTC isolates from Jos, Nigeria, based on spoligotyping,
and identify the families and subfamilies responsible for
the current persistence and spread of TB in this high-
incidence community.
Methods
Settings
Ethical clearance was granted respectively by The Jos
University Teaching Hospital and Plateau State Hospital
ethical committees. The study was descriptive of a bacte-
rial collection and contained no material of human ori-
gin. Personal data were removed from all bacterial
cultures to protect the anonymity of the patients. Patient
informed consent was therefore not obtained.
Sputum culture and Drug susceptibility test
Smear positive sputa from (93 new, 16 followup and 2
failed) cases of pulmonary TB were collected when avail-
able from the out patient department of 4 different TB-
treatment centers in Jos. Specimens were processed for
cultures of Mycobacterium species on Lowenstein Jensen
(LJ) medium at the Department of Medical Microbiology,
University of Jos, Nigeria as described previously [6].
A total of 77 of the 111 isolates that were phenotypi-
cally identified as MTC as previously described [5], were
tested for drug susceptibility by the proportion method
on LJ medium using 0.2 μg isoniazid (INH), 2 μg ethamb-
utol (EMB), 40 μg rifampicin (RIF) and 4 μg streptomycin
STR) [5].
Spoligotyping
Cultures were heat inactivated at 80° for 20 minutes. A
total of 111 heat-killed MTC strains were sent to the
National Reference Laboratory for M ycobacteria at the
Norwegian Institute of Public Health (NIPH). Upon
arrival, DNA was extracted and spoligotyping performed
as described elsewhere [7].
DNA was extracted and spoligotyping was performed
according to Kamerbeek et al. [7]. A single linkage den-
drogram was produced by use of the Bionumerics, ver-
sion 5.1 software (Applied Maths, Kortrijk, Belgium).
Family assignment
The obtained spoligopatterns were first compared to the
SpolDB4 database and assigned to families and subfami-
lies [9]. Second, in order to assign names to the isolates
not found in the SpolDB4 database, the spoligopatterns
were analyzed with 'Spotclust', using a mixture model
built on the SpolDB3 database [10]. This model takes into
account knowledge of the evolution of the DR region and
assigns spoligopatterns to families and subfamilies. The
rate of diversity was calculated by dividing the number of
spoligotypes by the number of isolates.
Results
Genetic diversity and family assignment
The 111 analyzed isolates gave 29 different spoligopat-
terns resulting in an overall diversity (number of spoligo-
types divided by the number of isolates) of 27. A total of
17 spoligopatterns occurred only once and 1 pattern
comprised 65% of the isolates (Figure 1). All patterns had
been described previously [9]. Family assignment by use
of the SpolDB4 database and 'Spotclust' showed that 84
(76%) of the isolates belonged to the Latin American
Mediterranean (LAM) family, 79 (93%) of these belonged
to the LAM 10 family. A total of 10 (9%) of the isolates
were assigned to the Haarlem family, 6 (5%) to the X fam-
ily, 4 (4%) to the T family, 4 (4%) to the F family, and 2
(2%) to the EAI family. One isolate was assigned to M.
africanum. The low spoligotype diversity within the MTC
population was confirmed by construction of a dendro-
gram. Most isolates demonstrated more than 90% homol-
ogy, and only 6 isolates were less than 80% homologous to
the other strains (Figure 1). The LAM10 clearly domi-
nated the TB epidemic in Jos.
The abundance of the LAM family in this area may
indicate that the family is either well adapted to spread,
highly conserved, or recently transmitted within this
community. The observation of only one isolate of M.
africanum  was unexpectedly low, as previous studies
have demonstrated that approximately 13% of TB in
humans in Ibadan, Nigeria was caused by M. africanum
type I and M. bovis [2,3].
Drug susceptibility tests were available from 77/111
isolates in this study. A total of 31 strains were resistant to
at least one drug, and 19 strains were multidrug resistant
(resistant to at least rifampicin and isoniazid) (MDR)
strains (Table 1). Although the numbers were low, it was
noted that 16/56 tested LAM10 isolates were MDR and
3/4 tested Haarlem-family isolates were MDR.
Discussion
This study demonstrated that LAM10 isolates were abun-
dant in the current population of MTC isolates from Jos,Ani et al. BMC Infectious Diseases 2010, 10:189
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Nigeria. A study conducted in the West province of Cam-
eroon found that 193 of 413 M. tuberculosis isolates
belong to the Cameroon family (LAM10-CAM) [11], and
in Harare, Zimbabwe, 68 of 214 isolates are LAM11-ZWE
variants [12]. In Dar Es Salaam, Tanzania however, the
overall genetic diversity was calculated at 52 and only 3 of
147 isolates were LAM 10 strains [13]. Of the 111 isolates
in this study, 78 were LAM10 and no LAM11 isolates
were observed. Although other lineages are found in
other countries, these findings indicate that various LAM
sub-families dominate in various regions of Africa and
that TB epidemics are multiple and local. Other lineages
that are abundant in other African countries (such as the
LAM11) were absent in the current study. Thus, the MTC
populations in high-incidence countries may vary greatly
and can be difficult to estimate without molecular epide-
miological studies.
The success of the LAM family in particular in this
community is intriguing. The highly prevalent LAM10
family in this study may indicate that the family is spread-
ing rapidly, but could also reflect a slow evolution of the
DR region. However, one limitation of the current study
is related to the uncertainty about the accurate represen-
tation of MTC population of Jos, Nigeria. Also, the lack of
the more discriminatory methods such as, IS6110 RFLP
and MIRU-VNTR typing [14-16], prevents more conclu-
sive results.
The predominance of the LAM family in South Amer-
ica and West-Africa suggests a possible co-evolution
between specific MTC families and host populations
[9,17]. The molecular basis of this theory remains to be
elucidated but this pattern might reflect the last centu-
ries' transport and interaction between these continents
and the genetic relatedness between Western Africa and
the Americas.
The rates of drug susceptibility to first line anti tuber-
culosis drugs were evenly distributed among the genetic
lineages in the current study (Table 1). This may indicate
strain-strain heterogeneity or other factors which could
not be explained within the scope of this study. Genetic
fingerprinting methods with higher discriminatory ten-
dencies are required for better interpretation of the
results.
Conclusions
Spoligotyping performed in this study was useful with
insights on the local TB epidemic in Jos, Nigeria. This
study demonstrated that the extensive TB epidemic in
this area was caused by one successful M. tuberculosis
family, dominated by the LAM10 subfamily. Import of
Figure 1 Spoligopatterns and identity of Mycobacterium tuberculosis complex strains from Jos, Nigeria. Genetic similarity and spoligopattern 
of M. tuberculosis Complex isolates from Jos in Nigeria. The population demonstrates a high degree of homogeneity and dominance of LAM10.Ani et al. BMC Infectious Diseases 2010, 10:189
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new strains from neighboring countries appears to repre-
sent a minor problem, but such interpretation need con-
firmation. The spread of TB in this area may however be
locally restricted.
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